Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891618-97-001492
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 222692
2 1994 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN EX-10.26 18209
3 1991 STOCK PURCHASE PLAN, AS AMENDED EX-10.29 22014
4 1991 EQUITY INCENTIVE PLAN, AS AMENDED EX-10.30 32858
5 FIRST AMENDMENT TO COLLABORATION AGREEMENT EX-10.35 5982
6 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT EX-10.36 73168
7 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT EX-10.37(I) 6079
8 AMENDMENT NO. 2 TO COLLABORATION AGREEMENT EX-10.37(II) 16412
9 AMENDMENT NO. 3 TO COLLABORATION AGREEMENT EX-10.37(III) 4921
10 AMENDMENT NO. 5 TO COLLABORATION AGREEMENT EX-10.37(IV) 92278
11 DESCRIPTION OF 1996 INCENTIVE PAY PLAN EX-10.38 979
12 CONSENT OF ERNST & YOUNG LLP EX-23.1 837
13 FINANCIAL DATA SCHEDULE EX-27 2434
  Complete submission text file 0000891618-97-001492.txt   501621
Mailing Address
Business Address 256 E GRAND AVE STE 80 SOUTH SAN FRANCISCO CA 94080 4152446800
COR THERAPEUTICS INC / DE (Filer) CIK: 0000874865 (see all company filings)

EIN.: 943060271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19290 | Film No.: 97568516
SIC: 2834 Pharmaceutical Preparations